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Single Cell Transfection through 
Precise Microinjection with 
Quantitatively Controlled Injection 
Volumes
Yu Ting Chow1,*, Shuxun Chen1,*, Ran Wang1, Chichi Liu2, Chi-wing Kong3, Ronald A. Li3, 
Shuk Han Cheng2 & Dong Sun1
Cell transfection is a technique wherein foreign genetic molecules are delivered into cells. To elucidate 
distinct responses during cell genetic modification, methods to achieve transfection at the single-
cell level are of great value. Herein, we developed an automated micropipette-based quantitative 
microinjection technology that can deliver precise amounts of materials into cells. The developed 
microinjection system achieved precise single-cell microinjection by pre-patterning cells in an array and 
controlling the amount of substance delivered based on injection pressure and time. The precision of the 
proposed injection technique was examined by comparing the fluorescence intensities of fluorescent 
dye droplets with a standard concentration and water droplets with a known injection amount of the 
dye in oil. Injection of synthetic modified mRNA (modRNA) encoding green fluorescence proteins or a 
cocktail of plasmids encoding green and red fluorescence proteins into human foreskin fibroblast cells 
demonstrated that the resulting green fluorescence intensity or green/red fluorescence intensity ratio 
were well correlated with the amount of genetic material injected into the cells. Single-cell transfection 
via the developed microinjection technique will be of particular use in cases where cell transfection is 
challenging and genetically modified of selected cells are desired.
Cell transfection is a process wherein foreign genetic substances (e.g., nuclei acids) are delivered into cells; this 
technique has been widely used to produce genetically modified cells. Genetic materials or gene products are 
usually delivered to enhance or inhibit specific gene expressions in cells so that the functions of the genes of 
interest could be studied1. The current methods of cell transfection involve bulk gene transfection, which requires 
large copy numbers of an expression vector per cell and relies on a stochastic process to deliver an average dose. 
Because the function of a cell is determined by its location and time, single-cell resolution of gene expression is 
important to elucidate gene functions. Thus, the design of a highly quantitative method to deliver precise amount 
of genetic modification substance into single cells is necessary.
Cell transfection methods may be broadly classified as biological, chemical, or physical methods1. Biological 
methods employ viral vectors to achieve gene transfer2, but they suffer from safety issues, such as promotion of 
immune responses or genetic mutations3. Chemical methods, such as lipofection reagents4,5, present the advan-
tages of safety, large-scale production, and capacity to deliver large gene fragments. However, the transfection 
efficiency of these methods is largely affected by the cell type, reagent formulation, and DNA/reagent ratio, among 
others6. Physical methods can achieve bulk transfection or single cell transfection by utilizing diverse physical 
tools for delivering genetic substances. Some physical methods, such as ultrasound-based sonoporation7, mag-
netic field-based magnetofection8, and electric field-based electroporation9, can transfect a large number of cells 
by creating transient holes in the cell membrane to allow nucleic acids passage. Other methods using laser irra-
diation10, mechanical constriction11, or micropipette penetration12 can also achieve transfection for specific cell 
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types or subcellular regions. However, although most physical methods can achieve specific delivery, they still rely 
on stochastic processes to deliver an average dosage and suffer from relatively low controllability of the amount 
of substance delivered.
Microinjection, a process of biological material delivery by insertion of a micropipette into living cells in 
culture, has been applied to many biomedical applications12–15, such as direct injection of nucleic acids into the 
cytoplasm or nucleus. Microinjection presents unique advantages during single-cell transfection, including cost 
savings through control of the amount of injected material delivered, applicability to different cell types and 
injection substances, and enhanced safety by virtue of its virus-free nature. Several microinjection systems have 
been integrated with robotics technology to enable automated injection with high transfection efficiency16–20. 
Most microinjection approaches focus on automating the injection process to overcome several problems that 
inherently exist during manual operation21, such as human fatigue and poor reproducibility. Only a few of these 
approaches have investigated single-cell transfection, which requires highly quantitative control of the delivered 
substance. Although manual quantitative microinjection has been applied to large-sized mouse embryos and 
zygotes to evaluate the effects of chemical compounds on embryo development22, delivery was neither automated 
nor reproducible and the process could not be applied to human cells, which usually range in size from 7 μm to 
25 μm. To create genetically modified cells with predictable functions, a reliable and high-throughput quantita-
tive microinjection technique that allows precise delivery of small amount of injection materials into a batch of 
human cells must be applied.
This article presents a new quantitatively controlled microinjection technique to achieve single-cell trans-
fection. Based on an automated micropipette-based microinjection platform23 that employs a microfluidic chip 
to pattern the suspended cells in an array for easy injection and measurement, a technology that could achieve 
precise delivery of controlled amounts of materials into cells was developed. Specifically, the injection volume was 
measured by volumetric changes in water droplets dispensed in mineral oil to permit measurable injections under 
different injection pressures and times. To examine the accuracy of the delivered volume, water droplets with sizes 
similar to that of human cells were injected with fluorescent dye under calibrated injection parameters. Thereafter, 
the injection amount was calculated from the fluorescence intensity of the droplets, and the results verified the 
effectiveness of the injection volume control technique in delivering small amounts of a substance into cells. 
Experiments wherein different amounts of synthetic modified mRNA (modRNA) or a cocktail of plasmids were 
delivered into human foreskin fibroblast (HFF) cells at different concentration ratios were then performed to 
demonstrate the effective control of the materials delivered. All of the experimental results confirmed that the 
proposed quantitative microinjection technique can be readily applied to achieve precise single-cell transfection.
Results
Injection volume calibration results. Control of the injection volume is achieved by adjusting the injec-
tion pressure and time. The micropipette was first calibrated with different injection parameters, and the injection 
volume was measured by examining the volumetric change in water droplets before and after microinjection. 
While Fig. 1a shows the water droplets dispensed in mineral oil before injection, Fig. 1b shows that the volume 
of the droplets increased after 1–30 injections. The computation results in Fig. 1c show the linear increase in the 
volume of the droplets with increasing injection pressure for an injection time of 100 ms. Figure 1d illustrates the 
linear increase in the volume of the water droplet with increasing injecting time under an injection pressure of 
21.4 kPa. In the following cell injection experiments, the injection time was maintained at 100 ms, and the applied 
pressure was adjusted to achieve the desired injection volume. The operation process was computer-controlled to 
ensure that it is repeatable and consistent.
Pseudo cell injection results. To verify the accuracy of the calibration results, tetramethylrhodamine iso-
thiocyanate (TRITC)-dextran was injected into water droplets dispensed in the cell trapping channel of a cell 
holder chip. Figure 2a illustrates variations in fluorescence intensity as a function of the TRITC-dextran concen-
tration; a strong linear correlation between the measured fluorescence intensity and the TRITC-dextran concen-
tration could be observed. The fluorescence intensity–TRITC concentration curve was obtained by dispensing a 
known concentration of TRITC-dextran solution in oil to form TRITC-dextran droplets and then measuring the 
resulting fluorescence intensity of each TRITC-dextran droplet. This curve is applied in this work as a standard 
curve to calculate TRITC-dextran concentration within water droplets after quantitative microinjection.
The injected water droplets, as shown in Fig. 2b, revealed similar fluorescence intensities (SD-to-Mean 
ratio = 0.124, n = 26), indicating that the precise injection volume is reproducible. Figure 2c shows that the fluo-
rescence intensity curve obtained based on increasing injection amounts of TRITC-dextran was linear and simi-
lar to the standard curve, subject to a maximum error of 20.3%. Similar result was obtained after TRICT-dextran 
was injected into HFF cells, as seen in Supplementary Fig. 1. This result verifies that the injection system is capable 
to deliver accurate volume to target cells.
modRNA injection results. Quantitative injection of modRNA encoding nuclear eGFP into HFF cells was 
performed. About 420 fL of modRNA of different concentrations (5, 20, and 100 ng/μL) were separately injected 
into HFF cells. Fluorescence signals were checked 18 h after injection. Figure 3a shows HFF cells with different 
eGFP intensities, which indicates that the cells received different amount of modRNA. As the amount of the 
injected modRNA increased, the HFF cells showed increasing eGFP intensities, which means more eGFP pro-
tein had been synthesized in the cell. Figure 3b shows the linear change in fluorescence intensity with increasing 
injection amount of the modRNA. The amount of mRNA can determine the protein expression level inside the 
cell, and our results indicated that the amount of synthesized protein inside the living cells could be controlled 
by quantitative microinjection of the modRNA. We further measured the transfection efficiency of delivering 
different amounts of modRNA to the HFF cells. The transfection efficiency is defined as the ratio of the number 
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of cells with nuclear eGFP to the number of injected cells. Figure 3c shows that the transfection efficiency was 
enhanced as the injected amount of modRNA increased. Transfection efficiency reached 80% when 100 ng/μL 
modRNA was injected into the cells. Since our previous experiment on TRITC-dextran injection of HFF cells 
showed a maximum injection efficiency of 88%23, further increases in modRNA injection amount may not show 
much increases in transfection efficiency.
Cell viability was investigated by incubating the cells in culture medium with 0.5 μM of SYTOX Orange dye 
(Molecular Probes) for 10 min. Supplementary Fig. 2a,b show the trapped cells in the cell holder chip without 
injection after 1 h incubation. It was found that 97.5% ± 2.0% (mean ± SD, n = 3) trapped cells were viable and 
adhered to cell holder chip. Supplementary Fig. 2c,d show the fluorescein isothiocyanate (FITC)-dextran injected 
cells in the cell holder after 1 h incubation. The viability of FITC-dextran injected cells could reach 82.1% ± 7.0% 
(mean ± SD, n = 3) examined by SYTOX Orange dye.
Plasmid cocktail injection results. DNA delivery into cells is also an important strategy in many cell 
biological studies. Cellular heterogeneity presents different cell behaviors among cells and plays a crucial role 
in studies of single-cell biology. We performed 14 plasmid cocktail injection experiments; in each experiment, a 
mixture of different ratios of plasmids encoding eGFP and plasmids encoding mCherry were injected into HFF 
cells. Figure 4a,b show the HFF cells 48 h after injection of eGFP and mCherry plasmids at ratios of 1:1 and 9:1, 
respectively. In these experiments, 11.8% ± 0.807% (mean ± SD) of the positive cells showed single eGFP expres-
sion, 4.10% ± 0.68% (mean ± SD) of the positive cells showed single mCherry expression, and 82.8% ± 2.99% 
(mean ± SD) of the positive cells showed co-expression of both eGFP and mCherry. The intensities of eGFP and 
mCherry were correlated with their injected plasmid concentrations in the cell. Figure 4c shows that the intensity 
ratio between eGFP and mCherry presents a linear relationship with the injected plasmid ratio. These results 
indicate that the ratio of synthesized target protein could be controlled by quantitatively injecting plasmids of an 
appropriate ratio into single cells.
Discussion
In this study, we demonstrated single-cell transfection by using a precise micropipette-based microinjection 
technology with a quantitatively controlled injection volume. The delivered amount of injected substance can 
be quantified in terms of injection pressure and time, as evidenced by our calibration study where the injection 
Figure 1. Injection amount calibration. (a) Water droplets dispensed in oil. (b) Water droplets after injection. 
Scale bar, 30 μm. (c) Linearity of injection volume versus injection pressure (R2 = 0.999, y = 181.1 + 97.3x).  
(d) Linearity of injection volume versus injection time (R2 = 0.999, y = 86.9 + 0.756x). Error bars in (c,d) 
indicate the SD of three independent experiments.
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volume was measured through volumetric changes in water droplets in mineral oil. The pseudo cell injection 
experiments verified that the proposed approach can achieve precise delivery of a small amount of fluorescent 
dye into target droplets, and the delivery amount and fluorescence intensity were linearly correlated. Compared 
with other transfection methods, such as electroporation and lipofection, the proposed method can potentially 
accomplish single-cell transfection regardless of the cell type or substance delivered. The effectiveness of the 
proposed technology was further demonstrated by injecting modRNA and a plasmid cocktail into HFF cells. 
Results agreed well with our hypothesis that higher concentrations of modRNA delivered can result in higher 
Figure 2. Pseudo Cell injection. (a) Fluorescence intensity as a function of TRITC-dextran concentration 
(R2 = 0.993, y = 5.05 + 66.9x, n = 5). (b) Droplets after TRITC-dextran injection. Scale bar, 50 μm.  
(c) Fluorescence intensity of pseudo cells after quantitative microinjection (R2 = 0.999, y = 9.66 + 26.9x).
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transfection efficiency before saturation is reached, thereby implying that the amount of substance delivered into 
the cells is a key factor in improving modRNA transfection efficiency. Our technology also allows microinjection 
of multiple components into a single cell. Experimental results of plasmid cocktail delivery into HFF cells verified 
that plasmid mixtures with different ratios of eGFP and mCherry could affect the amount of protein synthesized.
The proposed quantitative microinjection technique can be applied to study cell responses to different dosage 
of exogenous DNA or RNA. In general, modRNA delivery presents several advantages over plasmid DNA deliv-
ery in gene therapy applications24. Synthetic modified mRNA (modRNA) is a novel reprogramming tool gen-
erally used for controlled intracellular targeting and in situ logic evaluation of disease-related conditions25. The 
proposed method allows elucidation of single-cell gene expression in terms of number of RNA complexes deliv-
ered and number of proteins expressed through precise control of the delivery of modRNA. Moreover, RNA inter-
ference is steadily becoming a powerful tool to knockdown specific genes26. Our technique can serve as a more 
effective and reliable tool to deliver small inhibitory RNAs (siRNAs) in clinical applications. Yet another potential 
application of this method is injection of CRISPR/CAS9 systems for multiplex genome editing27. Delivery of 
CRISPR/CAS9 systems containing multiple genes of interest into cells could generate models for genetic dis-
ease studies28. Since the CRISPR/CAS9 system consists of multiple components and tight control of the dose 
and duration of CRISPR/CAS9 expression is critical for tuning targeting specificity29, the proposed quantitative 
Figure 3. Delivery of Different Concentrations of modRNA encoding Nuclear eGFP. (a) HFF cells injected 
with different concentrations of nuclear eGFP encoding modRNA. (b) Linear change in fluorescence intensity 
with increasing amount of injected modRNA (R2 = 0.966, y = 5.03 + 0.195x). Each measurement represents the 
mean ± SD of at least 46 cells. (c) Transfection efficiency of injection of different concentrations of modRNA. 
Each measurement represents the mean ± SD of at least 3 independent experiments.
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microinjection technology may present an ideal solution through which both donor plasmid and CRISPR/CAS9 
plasmid delivery into cells may be simultaneously accomplished to increase gene knock-in efficiency.
The proposed approach can be applicable across wide range of cell types, especially those with difficulty in 
treatment with traditional methods. The microinjection system can function as an enabling research tool for its 
ability of delivering virus-free DNA and RNA to transfect those challenged primary cells such as post-mitotic 
neurons30,31 and mesenchymal stem cells32. Through further advancement of microfluidic-based cell holder chip, 
high-throughput and multi-treatment modules can be further achieved.
Materials and Methods
Microinjection system setup. The microinjection experiments were conducted on an automated microin-
jection system as previously reported23. In brief, the system consisted of a 3-DOF robot manipulator to hold the 
injection pipette and cell holder chip, an objective lens equipped with a CCD camera for visual feedback, a micro-
injector to provide a positive injection pressure and a negative cell trapping pressure, and a PC with motion con-
trol for full automation programming. The vacuum-based cell holder chip with a two-layer structure of 256 cell 
trapping channels (See supplementary Fig. 3) can pattern cells on the array within 10 min. The optimal dimension 
of the trapping channel depended on the size of the targeted cells. The height of the trapping channel should be 
the same as or slightly smaller than the diameter of the target cell, while the thickness of supporting layer (see 
supplementary Fig. 3c) should be at least 4 times smaller than the diameter of the target cell.
Figure 4. eGFP and mCherry Plasmid Cocktail Injection. (a) HFF cell injected with a mixture of eGFP and 
mCherry plasmids at a 1:1 ratio. (b) HFF cells injected with a mixture of eGFP and mCherry plasmids at a 
9:1 ratio. (c) HFF cell without injection. Scale bar, 20 μm. (d) Ratio of eGFP/mCherry fluorescence intensity 
in relation to the ratio of the eGPF/mCherry plasmids (R2  = 0.998, y = 0.368 + 0.514x). Each measurement 
represents the mean ± SD of at least 50 cells.
www.nature.com/scientificreports/
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The cell holder chip was fabricated by soft lithography replica molding technology with polydimethylsiloxane 
(PDMS, SYLGARD). Briefly, two UV masks with feature of each layer were printed by a high-resolution printer. 
The mold was fabricated by patterning a photoresist (GM1050, Gersteltec Sàrl) on a silicon wafer using the 
UV-mask. Following post-exposure baking, the second UV mask was aligned precisely with the first mask layer 
using a mask aligner (MA6, Karl Suss). The photoresist was then developed to remove all unexposed portions and 
create a permanent mold. PDMS molding was carried out to obtain the reverse structure of the master. The fully 
cured PDMS was peeled off from the master and trimmed under a microscope with a 5 × objective (Mitutoyo, 
Japan). An outlet was punched through the PDMS using a sharpened syringe needle, and the trimmed chip was 
bonded to a cover glass surface using plasma cleaner (PDC-002, Harrick Plasma).
Cell culture. HFF cells were maintained in Dulbecco’s modified Eagle’s medium (Gibco) supplemented with 
10% fetal bovine serum (FBS, Gibco), 100 U/mL penicillin, and 100 U/mL streptomycin (Antibiotic-Antimycotic, 
Gibco) in a humidified atmosphere of 37 °C and 5% CO2.
Calibration. Volumetric changes in the droplets were used to characterize the injection volume of the micro-
pipette. The micropipettes were routinely fabricated from glass capillary tubes (BF100-50-15, Sutter Instruments) 
using a programmable laser-base pipette puller (P-2000, Sutter Instruments). The tip diameter of the fabricated 
micropipette was measured by scanning electron microscopy, and micropipettes with a tip inner diameter of 
0.5 μm were selected. After back filling with 1 μL of deionized water, the micropipette was fixed to the microrobot 
and connected to the microinjector, which controls the injection pressure and time. The pipette tip was then 
immersed into the mineral oil and water droplets were dispensed by adjusting the injection pressure or time. 
Since the droplets formed were very small, multiple injections were required to produce visible size changes in 
the droplets. Droplets were assumed to be spherical, and their volumes were determined by measuring the area 
of each droplet from captured images (See Supplementary Fig. 4a). The amount of injected substance could be 
determined by quantitatively injecting a certain volume of a substance with known concentration. Once the cali-
bration results of injection volume versus injection pressure and time were obtained, the calibrated micropipette 
could be used for cell injection.
Pseudo cell injection. Before pseudo cell injection, a standard fluorescence curve of TRITC-dextran was 
obtained by dispensing different concentration of TRITC droplets in oil and measuring the fluorescence intensity 
of the droplets. This curve was used to calculate the TRITC-dextran concentration for a given injected droplet.
For pseudo cell injection, negative pressure was applied to the outlet of the cell holder chip immersed in 
mineral oil. Each cell-trapping channel was inspected and all bubbles were removed. To create pseudo cells, the 
micropipette was filled with 1 μL of deionized water and inserted into the open end of a cell trapping channel. A 
20 μm-diameter water droplet was dispensed into each channel. After their creation, pseudo cells were injected 
with 3 mg/mL TRITC-dextran using a calibrated micropipette under predefined injection parameters. The inten-
sity of injected water droplets was measured and compared to that calculated from the standard curve based on 
TRITC-dextran concentration.
modRNA injection. The procedure of automated cell injection experiments is descripted in supplementary 
Fig. 4b. Prior to the injection experiments, single HFF cells obtained by enzymatic dissociation were rinsed three 
times with PBS and then suspended in the culture medium. The cell solution was gently pipetted up and down 
and then filtered through a 40 μm cell strainer to prevent blocking of the cell trapping channels by large cell clus-
ters. The sterilized cell holder chip was placed in a 35 mm culture dish, connected to the negative pressure source 
of the microinjector, and filled with cell culture medium. 20 μL of the prepared cell solution was transferred to the 
culture dish. The pressure was set to 54 Pa to trap the cells into the designed channels. After 10 min, the pressure 
was reduced and maintained at 7.2 Pa for cell immobilization during injection. The untrapped cells were gently 
flushed out of the cell holder chip by transfer pipette.
Synthetic modified mRNA (modRNA, StemMASTM) encoding nuclear eGFP was diluted to different concen-
trations with ultra-pure water (Gibco). The diluted mRNA was centrifuged at 150 × g for 15 min, and 1 μL of the 
supernatant was used to backfill the micropipette with a microloader (Eppendorf). Then the micropipette was 
mounted on the z-axis of the robot and manually inserted into the cell holder chip.
Injection was performed by the automated microinjection system. The system utilized template matching to 
recognize and locate cell positions, and the injection motion was controlled by a PID algorithm with visual-based 
position feedback. As the cells were patterned to predefined positions in an array, the injection motion was sim-
plified and the injection throughput increased. About 420 fL of modRNA was injected into the cell by controlling 
the injection pressure and injection time. For each injection experiment, about 200 cells were trapped on the cell 
holder chip and injected. Typically, the whole injection process including the cell loading procedure and injecting 
cell took about 1 h. After injection, the cells were maintained in the cell holder chip. The cell holder chip with 
injected cells was placed in a new culture dish with fresh culture medium, and eGFP signals were inspected 18 h 
after injection with an epi-fluorescence microscope equipped with the appropriate light source and filter sets. The 
transfection efficiency was determined by calculating the ratio of the number of nuclear eGFP positive cell after 
18 h of incubation to the number of the injected cells.
Cell viability was investigated by incubating the cells in culture medium with 0.5 μM of SYTOX Orange dye 
(Molecular Probes) for 10 min. SYTOX Orange dye could easily penetrate apoptotic cells with compromised 
plasma membranes, but would not penetrate healthy cell membranes. Cell viability after trapping and injection 
were evaluated.
The injected cells could be isolated after microinjection. After cell injection, the cell holder chip was rinsed 
with PBS and put into a new cell culture dish. The trapped cells were released from cell trapping channels by 
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supplying culture medium from chip outlet with positive pressure. Then, the cells were collected with culture 
medium from chip inlet using a liquid transferring pipette. Supplementary Fig. 5a shows a schematic of the cell 
retrieving process, and Fig. 5b shows the injected HFF cells retrieved from the cell holder chip and transferred to 
a glass bottom dish (MatTek Corporation) imaged after 1 day of culture.
Plasmid cocktail injection. Plasmids encoding eGFP and encoding mCherry were separately mixed at 
ratios of 1:5, 1:1, 5:1, and 9:1 to a final concentration of 5 ng/μL. The cell preparation and injection process was 
identical to that described for modRNA injection. Fluorescence signals were examined 48 h after injection. 
Successfully transfected cells were expected to present red and green fluorescence simultaneously. The trans-
fection efficiency was determined by calculating the ratio of the number of fluorescence labeled cell after 48 h of 
incubation to the number of the injected cells.
Imaging and measurement. Cell samples were imaged on a Zeiss Axio Vert.A1 microscope equipped with 
a CMOS camera (Axiocam 105 color). A mercury arc lamp (HBO 50) was used as the light source with the appro-
priate set of filter for the excitation and emission wavelengths. Fluorescence Images were acquired by AxioVision 
software and analyzed with ImageJ software.
Statistical analysis. All data are reported as mean ± standard deviation (SD) from at least three independ-
ent experiments. All statistical analyses were carried out with the Microsoft Excel software.
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